Athera is a biotechnology company focused on developing innovative therapies for autoimmune diseases. The company aims to address unmet medical needs by leveraging advanced scientific research and technology. Athera's pipeline includes treatments that target specific immune responses, potentially improving patient outcomes. Founded in Sweden, Athera collaborates with various research institutions and pharmaceutical companies to enhance its drug development efforts. The company is committed to advancing healthcare solutions and contributing to the understanding of autoimmune conditions, which affect millions of people worldwide.